Page last updated: 2024-10-29

4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline and Acute Myelogenous Leukemia

4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline has been researched along with Acute Myelogenous Leukemia in 1 studies

WHI P131: a quinazoline derivative, inhibitor of glioblastoma cell adhesion and migration

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Klaeger, S1
Heinzlmeir, S1
Wilhelm, M1
Polzer, H1
Vick, B1
Koenig, PA1
Reinecke, M1
Ruprecht, B1
Petzoldt, S1
Meng, C1
Zecha, J1
Reiter, K1
Qiao, H1
Helm, D1
Koch, H1
Schoof, M1
Canevari, G1
Casale, E1
Depaolini, SR1
Feuchtinger, A1
Wu, Z1
Schmidt, T1
Rueckert, L1
Becker, W1
Huenges, J1
Garz, AK1
Gohlke, BO1
Zolg, DP1
Kayser, G1
Vooder, T1
Preissner, R1
Hahne, H1
Tõnisson, N1
Kramer, K1
Götze, K1
Bassermann, F1
Schlegl, J1
Ehrlich, HC1
Aiche, S1
Walch, A1
Greif, PA1
Schneider, S1
Felder, ER1
Ruland, J1
Médard, G1
Jeremias, I1
Spiekermann, K1
Kuster, B1

Other Studies

1 other study available for 4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline and Acute Myelogenous Leukemia

ArticleYear
The target landscape of clinical kinase drugs.
    Science (New York, N.Y.), 2017, 12-01, Volume: 358, Issue:6367

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cytokines; Drug Discovery; fms-Like Tyrosine Kinas

2017